BREAST LOBULAR CARCINOMA IN SITU
Clinical trials for BREAST LOBULAR CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new BREAST LOBULAR CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for BREAST LOBULAR CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a lower tamoxifen dose prevent breast cancer in High-Risk women?
Prevention Recruiting nowThis study tests a low-dose tamoxifen plan to lower breast density, a key risk factor for breast cancer, in 200 premenopausal women at higher-than-average risk. Participants start on a low dose, and if their breast density doesn't drop enough, the dose is increased. The goal is t…
Matched conditions: BREAST LOBULAR CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Apr 29, 2026 15:07 UTC
-
Can fish oil boost Tamoxifen's power against breast cancer?
Prevention Recruiting nowThis study looks at whether adding high-dose omega-3 fatty acids to low-dose tamoxifen can better reduce breast cancer risk in overweight postmenopausal women who are already at higher risk. Tamoxifen blocks estrogen in breast tissue, while omega-3s may help with fat-related canc…
Matched conditions: BREAST LOBULAR CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Apr 28, 2026 13:02 UTC